Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction
© 2024. The Author(s)..
BACKGROUND: Long-term outcomes of lung transplantation (LTx) remain hampered by chronic lung allograft dysfunction (CLAD). Matrix metalloproteinase 9 (MMP-9) is a secretory endopeptidase identified as a key mediator in fibrosis processes associated with CLAD. The objective of this study was to investigate whether plasma MMP9 levels may be prognostic of CLAD development.
METHODS: Participants were selected from the Cohort in Lung Transplantation (COLT) for which a biocollection was associated. We considered two time points, year 1 (Y1) and year 2 (Y2) post-transplantation, for plasma MMP-9 measurements. We analysed stable recipients at those time points, comparing those who would develop a CLAD within the 2 years following the measurement to those who would remain stable 2 years after.
RESULTS: MMP-9 levels at Y1 were not significantly different between the CLAD and stable groups (230 ng/ml vs. 160 ng/ml, p = 0.4). For the Y2 analysis, 129 recipients were included, of whom 50 developed CLAD within 2 years and 79 remained stable within 2 years. MMP-9 plasma median concentrations were higher in recipients who then developed CLAD than in the stable group (230 ng/ml vs. 118 ng/ml, p = 0.003). In the multivariate analysis, the Y2 MMP-9 level was independently associated with CLAD, with an average increase of 150 ng/ml (95% CI [0-253], p = 0.05) compared to that in the stable group. The Y2 ROC curve revealed a discriminating capacity of blood MMP-9 with an area under the curve of 66%.
CONCLUSION: Plasmatic MMP-9 levels measured 2 years after lung transplantation have prognostic value for CLAD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Respiratory research - 25(2024), 1 vom: 09. Feb., Seite 88 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tissot, Adrien [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 14.02.2024 Date Revised 26.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12931-024-02707-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368262006 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368262006 | ||
003 | DE-627 | ||
005 | 20240229164331.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240210s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12931-024-02707-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1308.xml |
035 | |a (DE-627)NLM368262006 | ||
035 | |a (NLM)38336710 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tissot, Adrien |e verfasserin |4 aut | |
245 | 1 | 0 | |a Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.02.2024 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Long-term outcomes of lung transplantation (LTx) remain hampered by chronic lung allograft dysfunction (CLAD). Matrix metalloproteinase 9 (MMP-9) is a secretory endopeptidase identified as a key mediator in fibrosis processes associated with CLAD. The objective of this study was to investigate whether plasma MMP9 levels may be prognostic of CLAD development | ||
520 | |a METHODS: Participants were selected from the Cohort in Lung Transplantation (COLT) for which a biocollection was associated. We considered two time points, year 1 (Y1) and year 2 (Y2) post-transplantation, for plasma MMP-9 measurements. We analysed stable recipients at those time points, comparing those who would develop a CLAD within the 2 years following the measurement to those who would remain stable 2 years after | ||
520 | |a RESULTS: MMP-9 levels at Y1 were not significantly different between the CLAD and stable groups (230 ng/ml vs. 160 ng/ml, p = 0.4). For the Y2 analysis, 129 recipients were included, of whom 50 developed CLAD within 2 years and 79 remained stable within 2 years. MMP-9 plasma median concentrations were higher in recipients who then developed CLAD than in the stable group (230 ng/ml vs. 118 ng/ml, p = 0.003). In the multivariate analysis, the Y2 MMP-9 level was independently associated with CLAD, with an average increase of 150 ng/ml (95% CI [0-253], p = 0.05) compared to that in the stable group. The Y2 ROC curve revealed a discriminating capacity of blood MMP-9 with an area under the curve of 66% | ||
520 | |a CONCLUSION: Plasmatic MMP-9 levels measured 2 years after lung transplantation have prognostic value for CLAD | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Matrix Metalloproteinase 9 |2 NLM | |
650 | 7 | |a EC 3.4.24.35 |2 NLM | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Durand, Eugénie |e verfasserin |4 aut | |
700 | 1 | |a Goronflot, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Coiffard, Benjamin |e verfasserin |4 aut | |
700 | 1 | |a Renaud-Picard, Benjamin |e verfasserin |4 aut | |
700 | 1 | |a Roux, Antoine |e verfasserin |4 aut | |
700 | 1 | |a Demant, Xavier |e verfasserin |4 aut | |
700 | 1 | |a Mornex, Jean-François |e verfasserin |4 aut | |
700 | 1 | |a Falque, Loïc |e verfasserin |4 aut | |
700 | 1 | |a Salpin, Mathilde |e verfasserin |4 aut | |
700 | 1 | |a Le Pavec, Jérôme |e verfasserin |4 aut | |
700 | 1 | |a Villeneuve, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Boussaud, Véronique |e verfasserin |4 aut | |
700 | 1 | |a Knoop, Christiane |e verfasserin |4 aut | |
700 | 1 | |a Magnan, Antoine |e verfasserin |4 aut | |
700 | 1 | |a Lair, David |e verfasserin |4 aut | |
700 | 1 | |a Berthelot, Laureline |e verfasserin |4 aut | |
700 | 1 | |a Danger, Richard |e verfasserin |4 aut | |
700 | 1 | |a Brouard, Sophie |e verfasserin |4 aut | |
700 | 0 | |a COLT consortium |e verfasserin |4 aut | |
700 | 1 | |a Blanchard, Elodie |e investigator |4 oth | |
700 | 1 | |a Demant, Xavier |e investigator |4 oth | |
700 | 1 | |a Hulo, Virginie |e investigator |4 oth | |
700 | 1 | |a Ruiz-Patino, Maria |e investigator |4 oth | |
700 | 1 | |a Kuylen, Maarten Vander |e investigator |4 oth | |
700 | 1 | |a Sokolow, Youri |e investigator |4 oth | |
700 | 1 | |a Stefanidis, Constantin |e investigator |4 oth | |
700 | 1 | |a Huybrechts, Isabelle |e investigator |4 oth | |
700 | 1 | |a Perrin, Laurent |e investigator |4 oth | |
700 | 1 | |a Taccone, Fabio |e investigator |4 oth | |
700 | 1 | |a Etienne, Isabelle |e investigator |4 oth | |
700 | 1 | |a Knoop, Christiane |e investigator |4 oth | |
700 | 1 | |a Roussoulières, Anna |e investigator |4 oth | |
700 | 1 | |a Hites, Maya |e investigator |4 oth | |
700 | 1 | |a Lambert, Agnes |e investigator |4 oth | |
700 | 1 | |a Hemelsoet, Axelle |e investigator |4 oth | |
700 | 1 | |a Bedouch, Pierrick |e investigator |4 oth | |
700 | 1 | |a Briault, Amandine |e investigator |4 oth | |
700 | 1 | |a Falque, Loic |e investigator |4 oth | |
700 | 1 | |a Perrier, Quentin |e investigator |4 oth | |
700 | 1 | |a Raymond, Christel Saint |e investigator |4 oth | |
700 | 1 | |a Chacaroun, Samarmar |e investigator |4 oth | |
700 | 1 | |a Gioria, Yoann |e investigator |4 oth | |
700 | 1 | |a Quentin, Joane |e investigator |4 oth | |
700 | 1 | |a Grima, Renaud |e investigator |4 oth | |
700 | 1 | |a Drevet, Gabrielle |e investigator |4 oth | |
700 | 1 | |a Maury, Jean-Michel |e investigator |4 oth | |
700 | 1 | |a Tronc, François |e investigator |4 oth | |
700 | 1 | |a Portan, Philippe |e investigator |4 oth | |
700 | 1 | |a Mornex, Jean-François |e investigator |4 oth | |
700 | 1 | |a Du Vignaud, Claire Merveilleux |e investigator |4 oth | |
700 | 1 | |a Chatron, Eva |e investigator |4 oth | |
700 | 1 | |a Glérant, Jean Charles |e investigator |4 oth | |
700 | 1 | |a Turquier, Ségolène |e investigator |4 oth | |
700 | 1 | |a Mohamed, Salim Si |e investigator |4 oth | |
700 | 1 | |a Cottin, Vincent |e investigator |4 oth | |
700 | 1 | |a Chalabresse, Lara |e investigator |4 oth | |
700 | 1 | |a Dubois, Chantal |e investigator |4 oth | |
700 | 1 | |a Rea, Aurélie |e investigator |4 oth | |
700 | 1 | |a Reignier, Médéric |e investigator |4 oth | |
700 | 1 | |a Canterini, Julia |e investigator |4 oth | |
700 | 1 | |a Carlier, Nicolas |e investigator |4 oth | |
700 | 1 | |a Boussaud, Véronique |e investigator |4 oth | |
700 | 1 | |a Guillemain, Romain |e investigator |4 oth | |
700 | 1 | |a D'Journo, Xavier-Benoit |e investigator |4 oth | |
700 | 1 | |a Thomas, Pascale-Alexandre |e investigator |4 oth | |
700 | 1 | |a Trousse, Delphine |e investigator |4 oth | |
700 | 1 | |a Brioude, Geoffrey |e investigator |4 oth | |
700 | 1 | |a Boulate, David |e investigator |4 oth | |
700 | 1 | |a Fourdrain, Alex |e investigator |4 oth | |
700 | 1 | |a Bregeon, Fabienne |e investigator |4 oth | |
700 | 1 | |a Delliaux, Stéphane |e investigator |4 oth | |
700 | 1 | |a Reynaud-Gaubert, Martine |e investigator |4 oth | |
700 | 1 | |a Coltey, Bérengère |e investigator |4 oth | |
700 | 1 | |a Dufeu, Nadine |e investigator |4 oth | |
700 | 1 | |a Coiffard, Benjamin |e investigator |4 oth | |
700 | 1 | |a Bermudez, Julien |e investigator |4 oth | |
700 | 1 | |a Nieves, Ana |e investigator |4 oth | |
700 | 1 | |a Dutau, Hervé |e investigator |4 oth | |
700 | 1 | |a Tronchetti, Julie |e investigator |4 oth | |
700 | 1 | |a Gaubert, Jean-Yves |e investigator |4 oth | |
700 | 1 | |a Habert, Paul |e investigator |4 oth | |
700 | 1 | |a Di Biscéglie, Mathieu |e investigator |4 oth | |
700 | 1 | |a Basire, Agnes |e investigator |4 oth | |
700 | 1 | |a Pedini, Pascal |e investigator |4 oth | |
700 | 1 | |a Daviet, Florence |e investigator |4 oth | |
700 | 1 | |a Guervilly, Christophe |e investigator |4 oth | |
700 | 1 | |a Hraiech, Sami |e investigator |4 oth | |
700 | 1 | |a Forel, Jean Marie |e investigator |4 oth | |
700 | 1 | |a Delamarre, Louis |e investigator |4 oth | |
700 | 1 | |a Charvet, Aude |e investigator |4 oth | |
700 | 1 | |a Gragueb-Chatti, Ines |e investigator |4 oth | |
700 | 1 | |a Mora, Pierre |e investigator |4 oth | |
700 | 1 | |a Laurent, Daniel |e investigator |4 oth | |
700 | 1 | |a Giusiano, Sophie |e investigator |4 oth | |
700 | 1 | |a Dales, Jean-Philippe |e investigator |4 oth | |
700 | 1 | |a Gaubert, Mélanie |e investigator |4 oth | |
700 | 1 | |a Laine, Marc |e investigator |4 oth | |
700 | 1 | |a Lacoste, Philippe |e investigator |4 oth | |
700 | 1 | |a Perigaud, Christian |e investigator |4 oth | |
700 | 1 | |a Roussel, Jean-Christian |e investigator |4 oth | |
700 | 1 | |a Senage, Thomas |e investigator |4 oth | |
700 | 1 | |a Mugniot, Antoine |e investigator |4 oth | |
700 | 1 | |a Danner, Isabelle |e investigator |4 oth | |
700 | 1 | |a Tissot, Adrien |e investigator |4 oth | |
700 | 1 | |a Bry, Charlotte |e investigator |4 oth | |
700 | 1 | |a Penhouet, Morgane |e investigator |4 oth | |
700 | 1 | |a Eschapasse, Emmanuelle |e investigator |4 oth | |
700 | 1 | |a Horeau-Langlard, Delphine |e investigator |4 oth | |
700 | 1 | |a Blanc, François-Xavier |e investigator |4 oth | |
700 | 1 | |a Lepoivre, Thierry |e investigator |4 oth | |
700 | 1 | |a Vourch, Mickael |e investigator |4 oth | |
700 | 1 | |a Brouard, Sophie |e investigator |4 oth | |
700 | 1 | |a Danger, Richard |e investigator |4 oth | |
700 | 1 | |a Bernard, Megguy |e investigator |4 oth | |
700 | 1 | |a Godard, Elodie |e investigator |4 oth | |
700 | 1 | |a Valéro, Régine |e investigator |4 oth | |
700 | 1 | |a Maugendre, Karine |e investigator |4 oth | |
700 | 1 | |a Durand, Eugénie |e investigator |4 oth | |
700 | 1 | |a Yeremenko, Nataliya |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Respiratory research |d 2000 |g 25(2024), 1 vom: 09. Feb., Seite 88 |w (DE-627)NLM115627553 |x 1465-993X |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2024 |g number:1 |g day:09 |g month:02 |g pages:88 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12931-024-02707-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2024 |e 1 |b 09 |c 02 |h 88 |